Real-World Impact of Bimekizumab on Disease Activity in axial spondyloarthritis patients including the EARLY subpopulation (EXPEDITE)

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study

Study drug and medical condition

• Name of medicine:
  BIMZELX
• Study drug International non-proprietary name (INN) or common name:
  BIMEKIZUMAB
• Anatomical Therapeutic Chemical (ATC) code:
  (L04AC21) bimekizumab

  bimekizumab
• Medical condition to be studied:
  Axial spondyloarthritis